Zobrazeno 1 - 10
of 360
pro vyhledávání: '"E, Bloch-Michel"'
Publikováno v:
European Journal of Ophthalmology. 8:207-216
Purpose The aim of the study was to assess the efficacy and safety of 0.05% levocabastine eyedrops (H1 receptor blocker given BID + vehicle BID) compared with 0.1% lodoxamide ophthalmic solution (mast-cell stabilizer instilled QID) in reducing ocular
Publikováno v:
Ocular Immunology and Inflammation. 2:93-99
A new method for the tear IgE measurement Stallerdiag-IgE is presented. For this assay, the tears are collected on a strip of filter paper introduced into the conjunctival cul-de-sac. Then the IgE are measured by a simple enzymo-immunological assay.
Publikováno v:
International Ophthalmology. 16:75-80
In intraocular parasitosis the immunologic reactions in the vitrectomy-fluids depend on the parasitic agent: there is a lymphocytical reaction without any IgE production in toxoplasmic chorioretinitis, whereas there is a strong hypersensitivity react
Publikováno v:
Revue Française d'Allergologie et d'Immunologie Clinique. 30:237-240
Resume Le but de cette etude, realisee sur 78 sujets presentant diverses formes d'allergie conjonctivale, 16 sujets ayant une inflammation chronique de la conjonctive d'origine non allergique, 18 sujets ayant une inflammation d'origine non determinee
Publikováno v:
European annals of allergy and clinical immunology. 35(9)
Diagnosis of allergic rhinoconjunctivitis, particularly in chronic forms, remains sometimes difficult. Systemic tests such as skin or blood tests may be not sufficient to assess local sensitization. Local tests are needed, performed from nasal secret
Publikováno v:
European journal of ophthalmology. 11(2)
PURPOSE. To compare the clinical efficacy and safety of lodoxamide 0.1% ophthalmic solution with levocabastine 0.05% ophthalmic suspension, each given four times daily (QID) for three months to patients with vernal keratoconjunctivitis (VKC). METHODS
Autor:
Adolfo Sebastiani, A Di Giovanni, P Verin, D Denis, E Bloch-Michel, M Tazartes, L Helleboid, M Lecorvec
Publikováno v:
The British journal of ophthalmology. 82(10)
BACKGROUND/AIMS—Lodoxamide tromethamine and N-acetyl-aspartyl glutamic acid (NAAGA) are mast cell stabilisers, both of which have been shown to be effective in the treatment of allergic conjunctivitis. The aim of this study was to compare the two c
Publikováno v:
European journal of ophthalmology. 8(4)
The aim of the study was to assess the efficacy and safety of 0.05% levocabastine eyedrops (H1 receptor blocker given BID + vehicle BID) compared with 0.1% lodoxamide ophthalmic solution (mast-cell stabilizer instilled QID) in reducing ocular signs a
Autor:
E. Bloch-Michel
Publikováno v:
Revue Française d'Allergologie et d'Immunologie Clinique. 30:163-165
Resume 23 sujets atteints de conjonctivite printaniere ou semiprintaniere ont ete traites par une nouvelle molecule dont on a apprecie l'efficacite therapeutique lors d'un essai ouvert. Les scores quantifies des signes cliniques, subjectifs et object
Publikováno v:
International ophthalmology. 21(4)
Changes in local immunity are important when considering the physiopathology of uveitis. The aim of this study was to measure IgG and IgG subclass concentrations in the serum and the AH of patients with three different types of uveitis and to determi